Business Description
3B BlackBio Dx Ltd
ISIN : INE994E01018
Compare
Compare
Traded in other countries / regions
532067.India IPO Date
1996-10-23Description
3B BlackBio Dx Ltd is an Indian company specializing in PCR-based Molecular Diagnostic Kits. The company is involved in designing, developing, manufacturing, and commercializing PCR-based Molecular Diagnostic kits, PCR Enzymes, and PCR Reagents.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 72.34 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 323.04 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 32.66 | |||||
| Beneish M-Score | -2.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -34.1 | |||||
| 3-Year EBITDA Growth Rate | -36.1 | |||||
| 3-Year EPS without NRI Growth Rate | -40.2 | |||||
| 3-Year FCF Growth Rate | -37.7 | |||||
| 3-Year Book Growth Rate | 13.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.45 | |||||
| 9-Day RSI | 35.82 | |||||
| 14-Day RSI | 42.43 | |||||
| 6-1 Month Momentum % | 85.61 | |||||
| 12-1 Month Momentum % | 87.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.04 | |||||
| Quick Ratio | 6.56 | |||||
| Cash Ratio | 3.51 | |||||
| Days Inventory | 140.88 | |||||
| Days Sales Outstanding | 163.34 | |||||
| Days Payable | 59.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.23 | |||||
| Dividend Payout Ratio | 0.07 | |||||
| Forward Dividend Yield % | 0.23 | |||||
| 5-Year Yield-on-Cost % | 0.22 | |||||
| 3-Year Average Share Buyback Ratio | -4.6 | |||||
| Shareholder Yield % | 0.32 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.54 | |||||
| Operating Margin % | 46.25 | |||||
| Net Margin % | 45.34 | |||||
| FCF Margin % | 33.36 | |||||
| ROE % | 17.26 | |||||
| ROA % | 15.69 | |||||
| ROIC % | 16.31 | |||||
| 3-Year ROIIC % | -369.36 | |||||
| ROC (Joel Greenblatt) % | 91.94 | |||||
| ROCE % | 23.07 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.88 | |||||
| PE Ratio without NRI | 35.65 | |||||
| Shiller PE Ratio | 36.27 | |||||
| Price-to-Owner-Earnings | 37.45 | |||||
| PEG Ratio | 1.18 | |||||
| PS Ratio | 14.46 | |||||
| PB Ratio | 5.07 | |||||
| Price-to-Tangible-Book | 5.07 | |||||
| Price-to-Free-Cash-Flow | 42.73 | |||||
| Price-to-Operating-Cash-Flow | 41.92 | |||||
| EV-to-EBIT | 21.59 | |||||
| EV-to-EBITDA | 21.11 | |||||
| EV-to-Revenue | 13.51 | |||||
| EV-to-FCF | 40.5 | |||||
| Price-to-Projected-FCF | 1.98 | |||||
| Price-to-DCF (Earnings Based) | 1.5 | |||||
| Price-to-DCF (FCF Based) | 1.79 | |||||
| Price-to-Median-PS-Value | 5.78 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.72 | |||||
| Price-to-Graham-Number | 2.97 | |||||
| Price-to-Net-Current-Asset-Value | 11.51 | |||||
| Price-to-Net-Cash | 30.98 | |||||
| Earnings Yield (Greenblatt) % | 4.63 | |||||
| FCF Yield % | 2.34 | |||||
| Forward Rate of Return (Yacktman) % | 23.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
3B BlackBio Dx Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 792.764 | ||
| EPS (TTM) (₹) | 41.363 | ||
| Beta | 1.13 | ||
| Volatility % | 45.81 | ||
| 14-Day RSI | 42.43 | ||
| 14-Day ATR (₹) | 69.514034 | ||
| 20-Day SMA (₹) | 1410.68 | ||
| 12-1 Month Momentum % | 87.02 | ||
| 52-Week Range (₹) | 660 - 1550 | ||
| Shares Outstanding (Mil) | 8.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
3B BlackBio Dx Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
3B BlackBio Dx Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
3B BlackBio Dx Ltd Frequently Asked Questions
What is 3B BlackBio Dx Ltd(BOM:532067)'s stock price today?
The current price of BOM:532067 is ₹1318.70. The 52 week high of BOM:532067 is ₹1550.00 and 52 week low is ₹660.00.
When is next earnings date of 3B BlackBio Dx Ltd(BOM:532067)?
The next earnings date of 3B BlackBio Dx Ltd(BOM:532067) is .
Does 3B BlackBio Dx Ltd(BOM:532067) pay dividends? If so, how much?
The Dividend Yield %  of 3B BlackBio Dx Ltd(BOM:532067) is 0.23% (As of Today), Highest Dividend Payout Ratio of 3B BlackBio Dx Ltd(BOM:532067) was 0.12. The lowest was 0.02. And the median was 0.07. The  Forward Dividend Yield % of 3B BlackBio Dx Ltd(BOM:532067) is 0.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers